CXCL8 and posterior cortical atrophy: There are several inhibitors developed that target IL-8 or its receptors CXCR1 and/or CXCR2 (Table 2), with several ongoing clinical trials in PCa targeting these pathways to evaluate their effectiveness (summarized in Table 3).